First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Short Interest Update

First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) was the target of a significant increase in short interest in April. As of April 30th, there was short interest totaling 26,983 shares, an increase of 127.1% from the April 15th total of 11,879 shares. Currently, 3.0% of the company’s stock are sold short. Based on an average daily volume of 10,674 shares, the short-interest ratio is currently 2.5 days.

Institutional Investors Weigh In On First Trust Nasdaq Pharmaceuticals ETF

A number of large investors have recently made changes to their positions in FTXH. LPL Financial LLC grew its holdings in shares of First Trust Nasdaq Pharmaceuticals ETF by 40.5% during the fourth quarter. LPL Financial LLC now owns 146,105 shares of the company’s stock valued at $4,813,000 after buying an additional 42,147 shares during the last quarter. Marshall Investment Management LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at $1,377,000. OLD Mission Capital LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at $528,000. Sound Income Strategies LLC purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter valued at $287,000. Finally, Stratos Wealth Partners LTD. purchased a new stake in shares of First Trust Nasdaq Pharmaceuticals ETF during the third quarter valued at $230,000.

First Trust Nasdaq Pharmaceuticals ETF Trading Down 1.6%

Shares of FTXH stock traded down $0.55 during trading hours on Friday, reaching $33.87. 6,220 shares of the company’s stock were exchanged, compared to its average volume of 7,624. The stock’s 50 day moving average is $34.01 and its 200-day moving average is $33.42. The company has a market cap of $30.48 million, a price-to-earnings ratio of 14.51 and a beta of 0.47. First Trust Nasdaq Pharmaceuticals ETF has a fifty-two week low of $24.86 and a fifty-two week high of $35.61.

First Trust Nasdaq Pharmaceuticals ETF Cuts Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Stockholders of record on Thursday, March 26th were given a dividend of $0.0573 per share. The ex-dividend date of this dividend was Thursday, March 26th. This represents a $0.23 dividend on an annualized basis and a dividend yield of 0.7%.

About First Trust Nasdaq Pharmaceuticals ETF

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.